CDK4/6 inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for CDK4/6 inhibitor (unspecified), covering 2024-09-25 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease [Phase 3]